Pharma firms upped lobbying 23% before TrumpRx launch
Drug companies involved in TrumpRx increased their lobbying efforts by 23% ahead of the program's launch, spending over $130 million in 2025.
Browsing Tag
Inflation
Bluevine Report: Small Business Profitability & PennyWise Finance Tips
Explore Bluevine's report on small business profitability and PennyWise's personal finance and travel tips.…
Inflation’s Impact on Grocery Prices and How CPG Brands Can Adapt
Inflation significantly impacts consumer spending power and business operations. Recent spikes have affected…
Expert Tips to Avoid Financial Stress During Holiday Season
Feeling overwhelmed this holiday season? Here are expert recommendations to avoid financial stress, from budgeting to creating your own traditions.
Doctrine to Delivery – POLITICO
Europe must embrace 'sovereignty done right' to build resilience and competitiveness through global investments,…
Trump asserts unprecedented drug price drop, provides no data
Trump claims a drastic drop in US drug prices due to invoking favored nations status, but provides no evidence to…
Defeating the Far Right: The Role of Economy and Ecology
Far-right ideologies are gaining ground globally due to economic instability. The pattern is consistent: economic failure breeds extremism, as seen in 20th-century fascism and post-2008 financial crisis nationalism.
Effects of Inflation Reduction Act’s Potential Disappearance
The House has approved a draft law that could potentially end America's clean-energy boom. The law could undermine…
Goldman Sachs Launches New ETF for Protection from Market Volatility
Goldman Sachs Asset Management launches new buffer ETF for downside protection amidst market volatility. The…
Medicare prescription drug cap begins in 2025
New Medicare prescription drug cap saves thousands of Alabamians money at the pharmacy, with annual copays capped at $2,000.